Negotiable: Paramount Recruitment: Python Developer - Bioinformatics London Paramount are working in partnership with Genomics England to expand their team in order to deliver success Paramount are working in partnership with Genomics England to expand their team in order to with the 100, London, England

Negotiable: Paramount Recruitment: Bioinformatics Project Manager Bioinformatics team, Central London, Permanent The 100,000 genomes project is a challenging and fast moving project with the aim to carry out whole genome sequencing on 100,000 participants. London, England

Funding Opportunity RFA-RM-18-010 from the NIH Guide for Grants and Contracts. The NIH Directors Early Independence Award supports exceptional investigators who wish to pursue independent research essentially directly after completion of their terminal doctoral/research degree or end of post-graduate clinical training, thereby forgoing the traditional post-doctoral training period and accelerating their entry into an independent research career. Applications are welcome from individuals of diverse backgrounds and perspectives and in any topic of relevance to the broad mission of NIH. The NIH Directors Early Independence Award is a component of the High-Risk, High-Reward Research program of the NIH Common Fund.

Familiarity with computational biology or bioinformatics. Effective account engagement including planning, opportunity creation and qualification, stakeholder...
From Microsoft - Fri, 23 Mar 2018 23:14:42 GMT - View all Redmond, WA jobs

In Computer Science, Bioinformatics, Machine Learning, or a related field Preferred. Experience collaborating with interdisciplinary teams....
From Microsoft - Fri, 23 Mar 2018 23:12:10 GMT - View all Redmond, WA jobs

Familiarity with computational biology or bioinformatics. 10+ years of experience in a software development role BS in computer science (or equivalent)....
From Microsoft - Fri, 23 Mar 2018 23:12:09 GMT - View all Redmond, WA jobs

Scientists are on the cusp of delivering on that potential, but data, computational power, and analysis are needed to make genomic information actionable....
From Microsoft - Fri, 23 Mar 2018 23:10:17 GMT - View all Redmond, WA jobs

Notice NOT-MH-18-030 from the NIH Guide for Grants and Contracts

Notice NOT-MH-18-029 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-FD-18-021 from the NIH Guide for Grants and Contracts. Food and Drug Administration/ Center for Devices and Radiological (CDRH) is announcing its intention to accept and consider a single source application for the award of a cooperative agreement in fiscal year 2018 to Conference of Radiation Control Program Directors, Inc. (CRCPD) in support of coordination of Federal and State actions to assure radiation protection of the American public. The primary purpose of this cooperative agreement is to assist CRCPD members (State radiation control programs) in their efforts to protect the public, radiation workers and patients from unnecessary radiation exposure. Its goals will include: 1.Producing radiation protection solutions that meet community needs. 2.Assisting States with improving tools for radiation control. 3.Coordinate Federal, State and Tribal activities to achieve effective solutions to present and future radiation control problems. 4.Be expected to obtain the States cooperation and participation on committees and working groups established to deal with individual problems. 5.Plan and facilitate an annual meeting, and develop and offer educational activities to demonstrate mutually beneficial techniques, procedures, and systems relevant to the mission of assuring radiation protection. 6.Establish committees to address, evaluate, and offer solutions for a wide range of radiation health and protection issues. 7. Providing training in radiation control for CRCPD members.

Funding Opportunity RFA-FD-18-011 from the NIH Guide for Grants and Contracts. As part of FDA's Advancing Regulatory Science Initiative, the Office of the Chief Scientist supports innovation aimed at development of new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of FDA-regulated products. This funding opportunity will provide support, depending on availability of FDA funding, for one or more of the following existing Centers of Excellence in Regulatory Science and Innovation (CERSIs): Yale University-Mayo Clinic, University of Maryland at College Park and Baltimore and Johns Hopkins University. The CERSI(s) will serve to advance the Agency's regulatory science goals predominantly through cutting-edge collaborative research with FDA; they may also provide training in regulatory science.

A newly-established laboratory in the Division of Human Biology seeks a postdoctoral fellow to engage in laboratory-based science....
From Fred Hutchinson Cancer Research Center - Thu, 22 Mar 2018 22:38:25 GMT - View all Seattle, WA jobs

Purpose Under the supervision of Dr. Brian Hoffmann, the student worker would assist in various research lab activities related to the laboratories’ focus on...
From Medical College of Wisconsin - Thu, 22 Mar 2018 21:08:16 GMT - View all Milwaukee, WI jobs

Funding Opportunity RFA-FD-18-014 from the NIH Guide for Grants and Contracts. Current product-specific bioequivalence (BE) guidance published by the Office of Generic Drugs for dry powder inhalers (DPIs) include in vitro testing recommendations for single actuation content and aerodynamic particle size distribution, as well as recommendations for a pharmacokinetic study and a pharmacodynamic or clinical endpoint study. Given the extensive nature of current DPI BE guidance, it is desirable that current in vitro testing for DPIs be more reflective of in vivo performance. Computational fluid dynamics (CFD) and discrete element modeling (DEM) have been used to predict dry powder aerosol behavior, including the effects of agglomeration and deagglomeration. The purpose of the study will be to develop a CFD-DEM model which can be used to evaluate the impact of various physicochemical properties and device performance properties on regional deposition, to identify potentially biorelevant ranges for these properties that may be useful for future BE recommendations.

Make timely and sound decisions based on analysis of information, experience, and logic. Coordinate research protocols including arranging necessary...
From Medical College of Wisconsin - Thu, 22 Mar 2018 15:07:48 GMT - View all Milwaukee, WI jobs

Funding Opportunity RFA-FD-18-012 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity is to support the research and development necessary to advance non-invasive (e.g., spectroscopic/ imaging tomography) technologies, methods, study designs, and methods of data analysis to characterize and compare the rate and extent to which a topically applied drug becomes available at or near a site of action within the skin. The expectation is that the funded work will produce an accurate, sensitive and reproducible approach that measures the amount of drug present in the skin at a series of depths below the skin surface, which can be utilized to monitor the cutaneous pharmacokinetics (PK) of the drug at selected depths (e.g., in the epidermis or dermis) by repeated measurements over time. The ultimate intent is to support the eventual development of an alternative, scientifically valid, cutaneous PK-based approach to efficiently evaluate the bioequivalence (BE) of topical products in vivo in human subjects.

Negotiable: Paramount Recruitment: Software Developer - Bioinformatics Fixed Term Contract - Sept 2019 Cambridge This is a great opportunity for a strong Python or Perl developer to join a world-leading bioinformatics/ genomics organisation based in Cambridge. You will be responsible for Cambridge, England

This contact is for accommodation requests only and cannot be used to inquire about the status of applications....
From Novo Nordisk - Wed, 21 Mar 2018 21:24:18 GMT - View all Seattle, WA jobs

Funding Opportunity PAR-18-717 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to encourage applications for research training programs to strengthen the scientific capacity of institutions in low- and middle-income countries (LMICs) to conduct HIV research relevant to the evolving HIV epidemic in their country

Funding Opportunity PAR-18-716 from the NIH Guide for Grants and Contracts. The overall goal of this initiative is to support the development of a sustainable critical mass of bioethics scholars in low and middle-income country (LMIC) research intensive institutions with the capabilities to conduct original empirical or conceptual ethics research that addresses challenging issues in health research and research policy in these countries as well as provide research ethics leadership to their institutions, governments and international research organizations. FIC will support LMIC-U.S. collaborative institutional bioethics doctoral and postdoctoral research training programs that incorporate didactic, mentored research and training components to prepare a number of individuals with ethics expertise for positions of scholarship and leadership in health research institutions in the LMIC.